Literature DB >> 9204657

Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence.

P Lawlor1, P Walker, E Bruera, S Mitchell.   

Abstract

A case of severe opioid toxicity is described in a 52-year-old cancer patient. The patient presented with classical clinical features of central hyperexcitability associated with opioid toxicity: delirium, myoclonus, hallucinations, hyperalgesia, and a possible seizure. This patient had a background of severe psychosocial distress and somatization in addition to a history of benzodiazepine dependence and alcohol abuse. The occurrence of opioid toxicity in this patient highlights the risks of a unidimensional approach to cancer pain, which ignores the non-organic components of pain, such as psychosocial distress, which will not respond to escalating doses of opioid medication.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9204657     DOI: 10.1016/s0885-3924(97)00081-x

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  11 in total

Review 1.  [Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain].

Authors:  J Jage; A Willweber-Strumpf; C Maier
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

Review 2.  Strategies for the treatment of cancer pain in the new millennium.

Authors:  C Ripamonti; E D Dickerson
Journal:  Drugs       Date:  2001       Impact factor: 9.546

3.  Frequency, Predictors, and Medical Record Documentation of Chemical Coping Among Advanced Cancer Patients.

Authors:  Jung Hye Kwon; Kimberson Tanco; Ji Chan Park; Angelique Wong; Lisa Seo; Diane Liu; Gary Chisholm; Janet Williams; David Hui; Eduardo Bruera
Journal:  Oncologist       Date:  2015-05-01

4.  Undocumented alcoholism and its correlation with tobacco and illegal drug use in advanced cancer patients.

Authors:  Rony Dev; Henrique A Parsons; Shana Palla; J Lynn Palmer; Egidio Del Fabbro; Eduardo Bruera
Journal:  Cancer       Date:  2011-03-28       Impact factor: 6.860

5.  Alcoholism screening in patients with advanced cancer: impact on symptom burden and opioid use.

Authors:  Henrique A Parsons; Marvin Omar Delgado-Guay; Badi El Osta; Ray Chacko; Valerie Poulter; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2008-09       Impact factor: 2.947

6.  The effect of oral methadone on the QTc interval in advanced cancer patients: a prospective pilot study.

Authors:  Suresh Reddy; David Hui; Badi El Osta; Maxine de la Cruz; Paul Walker; J Lynn Palmer; Eduardo Bruera
Journal:  J Palliat Med       Date:  2010-01       Impact factor: 2.947

7.  The use of very-low-dose methadone for palliative pain control and the prevention of opioid hyperalgesia.

Authors:  Shelley R Salpeter; Jacob S Buckley; Eduardo Bruera
Journal:  J Palliat Med       Date:  2013-04-04       Impact factor: 2.947

8.  Predictors of long-term opioid treatment among patients who receive chemoradiation for head and neck cancer.

Authors:  Jung Hye Kwon; David Hui; Gary Chisholm; Eduardo Bruera
Journal:  Oncologist       Date:  2013-05-30

9.  Impact of delirium and recall on the level of distress in patients with advanced cancer and their family caregivers.

Authors:  Eduardo Bruera; Shirley H Bush; Jie Willey; Timotheos Paraskevopoulos; Zhijun Li; J Lynn Palmer; Marlene Z Cohen; Debra Sivesind; Ahmed Elsayem
Journal:  Cancer       Date:  2009-05-01       Impact factor: 6.860

Review 10.  A "TNM" classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP).

Authors:  Robin L Fainsinger; Cheryl L Nekolaichuk
Journal:  Support Care Cancer       Date:  2008-03-04       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.